Go Pro
NYSE:MCK

McKesson Q1 2027 Earnings Report

McKesson logo
$793.32 -25.34 (-3.10%)
Closing price 03:59 PM Eastern
Extended Trading
$793.23 -0.08 (-0.01%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

McKesson EPS Results

Actual EPS
N/A
Consensus EPS
$9.59
Beat/Miss
N/A
One Year Ago EPS
N/A

McKesson Revenue Results

Actual Revenue
N/A
Expected Revenue
$103.82 billion
Beat/Miss
N/A
YoY Revenue Growth
N/A

McKesson Announcement Details

Quarter
Q1 2027
Time
After Market Closes
Conference Call Date
Wednesday, August 5, 2026
Conference Call Time
4:30PM ET

Conference Call Resources

McKesson Earnings Headlines

The $15 Gold Fund That Pays Up to $1,152/Month
Gold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying out up to $1,152 a month to regular investors - no mining stocks, no options, no physical metal required. Chief Income Strategist Tim Plaehn calls it a breakthrough strategy that transforms gold's rally into reliable monthly payouts. The next distribution is just days away.tc pixel
See More McKesson Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like McKesson? Sign up for Earnings360's daily newsletter to receive timely earnings updates on McKesson and other key companies, straight to your email.

About McKesson

McKesson (NYSE:MCK) (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers. McKesson also offers a range of technology and automation solutions — including pharmacy automation, supply chain management software, and analytics — designed to improve operational efficiency, inventory control and patient safety for its customers. In addition, the firm provides support services such as clinical program management, patient access and adherence services for specialty therapies, and commercial services for biopharma manufacturers.

McKesson serves a broad customer base that includes retail and independent pharmacies, long-term care providers, hospitals and health systems, physician offices and specialty clinics. While its operations are concentrated in the United States and Canada, the company works with global pharmaceutical manufacturers and participates in international supply chain activities. Its business model emphasizes integration between distribution, technology and services to support the delivery of medications and related care.

Led by a corporate management team focused on resilience and technology-enabled solutions, McKesson has leveraged its long history in healthcare distribution to prioritize supply chain reliability, digital transformation and expanded services for specialty and complex therapies. The company’s combination of logistics capabilities, service offerings and health-technology products positions it as a key intermediary in the U.S. healthcare system.

View McKesson Profile